← Back to home

FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Clinical trials for FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS explained in plain language.

Never miss a new study

Get alerted when new FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS trials appear

Sign up with your email to follow new studies for FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New brain scan dye aims for clearer pictures

Diagnosis Recruiting now

This study is testing a new dye called HRS-9231 used during MRI scans of the brain and spinal cord. The goal is to see if this new dye helps doctors see abnormal areas (lesions) as clearly or better than a dye already in use. About 250 adults with known or suspected brain/spinal …

Matched conditions: FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Phase: PHASE3 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Diagnosis

Last updated Mar 30, 2026 14:34 UTC

FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Get alerted when new FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS trials appear

New brain scan dye aims for clearer pictures